Cosmetic Manufacturers Preparing For MoCRA Safety Substantiation Should Look To EU – Attorneys
Manufacturers looking for a model of safety substantiation in order to comply with the US Modernization of Cosmetics Regulation Act of 2022 should consider the framework required by the EU’s Cosmetic Products Regulation, says Steptoe & Johnson associate Surya Kundu. Attorneys also discussed new requirements for adverse event reporting during a FDLI webinar on MoCRA.
You may also be interested in...
Canada’s prohibitions on cosmetic animal testing enter into force in December, largely in line with EU, California and other bans around the globe, but with some notable distinctions. “Now it's really time to increase the pressure in the US – action can't be far behind,” says Brandi Halls, chief ethics officer at Lush Cosmetics, North America.
The US Food and Drug Administration will have new cosmetics requirements to enforce under the Modernization of Cosmetic Regulations Act, as well as new funds and pressure “to make a show of this,” Locke Lord attorneys said in the law firm’s 31 May “MoCRA and You” webinar.
Amin Talati Wasserman attorney Angela Diesch discusses the priorities, questions and concerns among companies facing end-of-year deadlines under the Modernization of Cosmetic Regulations Act enacted in the final days of 2022.